@article{article, title  = {{Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease.}},

 url = {{http://eprints.whiterose.ac.uk/107826/ }},

 year = {{2000}},

 month = {{5}},

 author = {{Dobson LS and Lorigan PC and Coleman RE and Hancock BW}},

 doi = {{10.1054/bjoc.2000.1176}},

 volume = {{82}},

 journal = {{Br J Cancer}},

 issue = {{9}},

 pages = {{1547-1552}},

 note = {{Accessed on 2025/10/10}}}